VEGFA and type 2 diabetes mellitus: Compared to nondiabetes participants, T2DM patients had increased PWV (8.7 ± 1.5 vs. 7.6 ± 1.3, p = 0.031), aortic pulse BP (58 ± 20 vs. 49 ± 17, p = 0.011), Ang-2 (838 (473–1241) vs. 597 (274–1005), p = 0.018), and VEGF (72.2 (28–201.8) vs. 48.4 (17.4–110.1), p = 0.025) but reduced levels of AIx (21.7 ± 13.8 vs. 34 ± 12.9, p < 0.001) and Ang-1 (33.1 (24.7–42.1) vs. 41.1 (30–57.3), p = 0.01).